Literature DB >> 6260784

Immunologic cross-reactivity of the low density lipoprotein receptor from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver.

U Beisiegel, T Kita, R G Anderson, W J Schneider, M S Brown, J L Goldstein.   

Abstract

An antibody to the low density lipoprotein (LDL) receptor was prepared by immunization of rabbits with a partially purified receptor preparation from bovine adrenal cortex. Immunoglobulin G (IgG) isolated from the serum of immunized rabbits blocked the binding of 125I-LDL to intact bovine adrenal membranes as well as to the partially purified bovine adrenal LDL receptor. The anti-receptor IgG also blocked the binding, uptake, and degradation of 125I-LDL by monolayers of human fibroblasts and thus prevented the LDL-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase. A monovalent Fab fragment of th anti-receptor IgG retained the ability to inhibit LDL receptors of partially purified bovine adrenal cortex and monolayers of human fibroblasts. By immunofluorescence staining, the anti-receptor IgG was shown to bind to normal fibroblasts in discrete foci that were linearly arranged on the cell surface. No such foci were seen on fibroblasts from a patient with the receptor-negative form of homozygous familial hypercholesterolemia. The rabbit anti-receptor IgG also blocked the binding of 125I-LDL to membranes from dog and rat liver, but it did not prevent LDL binding to rabbit adrenal membranes or rabbit fibroblasts. The immunologic cross-reactivity of LDL receptors from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver indicates that the structure of this receptor has been widely conserved among animal species and tissues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260784

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The rate of internalization of different receptor-ligand complexes in alveolar macrophages is receptor-specific.

Authors:  D M Ward; J Kaplan
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

2.  Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11.

Authors:  S Schröder; A Niendorf; E Achilles; M Dietel; B C Padberg; U Beisiegel; H Dralle; M Bressel; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.

Authors:  M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

4.  cDNA cloning of the bovine low density lipoprotein receptor: feedback regulation of a receptor mRNA.

Authors:  D W Russell; T Yamamoto; W J Schneider; C J Slaughter; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.

Authors:  C Koo; M E Wernette-Hammond; Z Garcia; M J Malloy; R Uauy; C East; D W Bilheimer; R W Mahley; T L Innerarity
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Circadian rhythm in hepatic low-density-lipoprotein (LDL)-receptor expression and plasma LDL levels.

Authors:  S Balasubramaniam; A Szanto; P D Roach
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

7.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

Authors:  R C Kowal; J Herz; J L Goldstein; V Esser; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.

Authors:  R W Mahley; D Y Hui; T L Innerarity; K H Weisgraber
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Differential low density lipoprotein receptor-dependent formation of eicosanoids in human blood-derived monocytes.

Authors:  P B Salbach; E Specht; E von Hodenberg; J Kossmann; U Janssen-Timmen; W J Schneider; P Hugger; W C King; J A Glomset; A J Habenicht
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor.

Authors:  Da-Wei Zhang; Rita Garuti; Wan-Jin Tang; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.